Applications are open
Apply Today
While COVID stretches already stretched health care systems across Africa, the future of Africa’s health care insurance systems is full of opportunity, promising improved coverage and creative care delivery across all sectors of society.
For years, high income countries have directed resources to help fight malaria in developing nations. As the COVID-19 pandemic becomes a major health concern for developed nations, what might this mean for the future of malaria-prevention efforts in low-income countries?
On August 11, Russian President Vladimir Putin announced that a coronavirus vaccine developed in the country has been registered for use. Why is this news being condemned broadly by scientists around the world?
The discovery and use of antibiotics is one of public health’s great achievements, but antibiotic use is not without its problems. At therapeutic doses, antibiotics exert a strong selection pressure on the microbial community. When antibiotics interact with an infant’s developing microbiome, they can affect gut health and with it the child’s health for years to come.
Chloroquine and hydroxychloroquine are important therapies for those suffering from lupus, a complex auto-immune disease. As the world battles to overcome COVID-19, we must ensure continued availability of antimalarials to patients whose lives literally depend on them.
Ultimately, vaccines are beneficial, and human trials are essential in determining the safety of any vaccine. But how do we select candidates for vaccine tests? Fallout from unethical experiments is persistent, and we must insist on the most ethical and medically accurate appraisals of the vaccine landscape.